I suspect the market has nothing to project forward until an...

I suspect the market has nothing to project forward until an update on patient trial numbers is announced,
therefore the market is not assuming a dramatic trend reversal until such time.

I still see a lot of upside from our current position; to me, it would seem that the bottom is in yet again and we
can look forward to growth in the SP, but, we need that update on patient numbers.

Quarterly due after the end of this month...that may provide the commentary and insight needed to deviate or augment
the SP action away from the sentiment of the past year or so. All other collaborations such as 'Prostate Cancer with
Weil Cornell Medical and Ovarian Cancer work with MD Anderson Cancer Center has clearly moved much further
down on the IBX degustation menu for now.